Tedco awards $600K to tech firms - Puget Sound Business Journal (Seattle):

acklinegymejac1362.blogspot.com
The money was granted in collaboration withthe U.S. Army Medicalk Research and Materiel Command and the througjthe Ft. Detrick Technology Transfer Initiative. The purposse of the technology transfer program is to raise awarenesd of new and developing technologies and funding them to transitiomn as viable projectsfor follow-on funding in the markert place. Each company that received funding was awardefapproximately $50,000 between March 2008 and May making up the initiative’s second rounc of financial awards since its $750,000 programj extension. The funds for the program’s seconx phase were secured by Sen. Barbara Mikulski, D-Md., and Rep. Roscose G. Bartlett, R-Md.
“The [Ft. Detrick Technology Transfer Initiative] program is enablinhg area businesses to harness the technologies being developed at Fort Detrick and apply them to thecommercial sector,” said Mikulski. “This will lead to new productsd that have the power to create jobs andsave lives.” Mikulsk announced the first phase of the tech transfef program in March 2005 when 11 companies received in Rockville: The company is developing a healthh care technology called miTag which is a scalable wireless sensor solution for improving patient flow. in The company is developing a technology called the GeNova Screento isolate, and produce antibody-lik molecules.
in Rockville: The company is developing an on-demand biotech products including a combinatio vaccine against plagueand anthrax. BioAssay Workas LLC in Ijamsville: The company is developing a lateral-flow visual diagnostic test to detect and differentiate single sample multiplepathogenif poxviruses, including variola, vaccinia, and monkeypox. in The company is safety-testing a medica l product called ClotFoam, which is a non-compressible, intracavitarh hemostatic agent.
CynerGene IDMP in The companyis developing, validating and implementinhg a supplemental diagnosis of Malaria, HIV, and Dengue using its Infectious Disease Multiplex Panekl approach, which could allow for creatiomn of biosensors. LLC in Baltimore: The company is developingf required components and system framework to enable conversational interfaces fortelemedicinw tools. Such tools would allow professional medicsd touse voice, gesture, and othetr human-- computer interactions to access and document information in electronic medicalp records.
in Rockville: The company is developingh technology to preserve mammalian cells in dried format that can easilhybe re-hydrated for a variety of LLC in Frederick: The company is evaluating the effect of Imagilin patented probiotic s as a food supplement to enhance the immuner responsiveness of guinea pigs upon immunization or challenge with viruleny pathogens. The evaluation will suggest the ability of Imagilij patented probiotics to enhance the immunization ofa vaccine. in The company is developing micropatterned substrateds for viralinfectivity assays. Juxtopiq in Baltimore: The compan is customizing its Wearable Assistancde and SituationalAwareness (WASA) goggles and service to alloqw U.
S. Army combat medics to access and documentg information to electrical medical recordevia hands-free voice-requests and in Baltimore: The company is developing cell therapieds to treat brain and spinaol cord injuries.